Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Treatment Strategies in CKD Patients With Suspected Coronary Artery Disease.

Foley RN.

Am J Kidney Dis. 2019 Oct;74(4):438-440. doi: 10.1053/j.ajkd.2019.06.004. No abstract available.

PMID:
31543157
2.

Time to thrombectomy is associated with increased risk for dialysis catheter placement.

Hall D, Shaughnessy D, Drawz P, Akkina S, Esten A, Foley RN, Reule S.

J Ren Care. 2019 Dec;45(4):232-238. doi: 10.1111/jorc.12295. Epub 2019 Aug 26.

PMID:
31448871
3.

Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States.

Murphy DP, Drawz PE, Foley RN.

J Am Soc Nephrol. 2019 Jul;30(7):1314-1321. doi: 10.1681/ASN.2018100971. Epub 2019 Jun 5.

PMID:
31167823
4.

Race, Ethnicity, and End-of-Life Care in Dialysis Patients in the United States.

Foley RN, Sexton DJ, Drawz P, Ishani A, Reule S.

J Am Soc Nephrol. 2018 Sep;29(9):2387-2399. doi: 10.1681/ASN.2017121297. Epub 2018 Aug 9.

5.

Design of a clinical risk calculator for major clinical outcomes in patients with atherosclerotic renovascular disease.

Vassallo D, Foley RN, Kalra PA.

Nephrol Dial Transplant. 2018 Jun 22. doi: 10.1093/ndt/gfy157. [Epub ahead of print]

PMID:
29939316
6.

The impact of outpatient acute kidney injury on mortality and chronic kidney disease: a retrospective cohort study.

Leither MD, Murphy DP, Bicknese L, Reule S, Vock DM, Ishani A, Foley RN, Drawz PE.

Nephrol Dial Transplant. 2019 Mar 1;34(3):493-501. doi: 10.1093/ndt/gfy036.

7.

End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012.

Sexton DJ, Reule S, Foley RN.

Kidney Int Rep. 2017 Sep 18;3(1):148-154. doi: 10.1016/j.ekir.2017.09.003. eCollection 2018 Jan.

8.

Renal Consequences of Diabetes After Kidney Donation.

Ibrahim HN, Berglund DM, Jackson S, Vock DM, Foley RN, Matas AJ.

Am J Transplant. 2017 Dec;17(12):3141-3148. doi: 10.1111/ajt.14416. Epub 2017 Aug 14.

9.

Epidemiology and Risk Factors for Early Mortality After Dialysis Initiation.

Foley RN.

Semin Nephrol. 2017 Mar;37(2):114-119. doi: 10.1016/j.semnephrol.2016.12.001. Review.

PMID:
28410645
10.

Stable Angina in Advanced CKD.

Foley RN.

Am J Kidney Dis. 2017 Mar;69(3):328-330. doi: 10.1053/j.ajkd.2016.11.010. No abstract available.

PMID:
28236879
11.

Renal Function Profile in White Kidney Donors: The First 4 Decades.

Ibrahim HN, Foley RN, Reule SA, Spong R, Kukla A, Issa N, Berglund DM, Sieger GK, Matas AJ.

J Am Soc Nephrol. 2016 Sep;27(9):2885-93. doi: 10.1681/ASN.2015091018. Epub 2016 Feb 17.

12.

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.

Murray AM, Bell EJ, Tupper DE, Davey CS, Pederson SL, Amiot EM, Miley KM, McPherson L, Heubner BM, Gilbertson DT, Foley RN, Drawz PE, Slinin Y, Rossom RC, Lakshminarayan K, Vemuri P, Jack CR, Knopman DS.

Am J Kidney Dis. 2016 Apr;67(4):593-600. doi: 10.1053/j.ajkd.2015.11.008. Epub 2015 Dec 29.

13.

ESRD due to Multiple Myeloma in the United States, 2001-2010.

Reule S, Sexton DJ, Solid CA, Chen SC, Foley RN.

J Am Soc Nephrol. 2016 May;27(5):1487-94. doi: 10.1681/ASN.2014090876. Epub 2015 Oct 29.

14.

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.

Collins AJ, Foley RN, Gilbertson DT, Chen SC.

Kidney Int Suppl (2011). 2015 Jun;5(1):2-7.

15.

Randomized controlled trials 7: Analysis and interpretation of quality-of-life scores.

Foley RN, Parfrey PS.

Methods Mol Biol. 2015;1281:261-72. doi: 10.1007/978-1-4939-2428-8_15.

PMID:
25694315
16.

Randomized controlled trials 2: Analysis.

Foley RN.

Methods Mol Biol. 2015;1281:177-90. doi: 10.1007/978-1-4939-2428-8_10.

PMID:
25694310
17.

End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010.

Sexton DJ, Reule S, Solid CA, Chen SC, Collins AJ, Foley RN.

Hemodial Int. 2015 Oct;19(4):521-30. doi: 10.1111/hdi.12281. Epub 2015 Feb 17.

18.

End-stage renal disease attributed to acute tubular necrosis in the United States, 2001-2010.

Foley RN, Sexton DJ, Reule S, Solid C, Chen SC, Collins AJ.

Am J Nephrol. 2015;41(1):1-6. doi: 10.1159/000369832. Epub 2015 Jan 23.

19.

ESRD from lupus nephritis in the United States, 1995-2010.

Sexton DJ, Reule S, Solid C, Chen SC, Collins AJ, Foley RN.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):251-9. doi: 10.2215/CJN.02350314. Epub 2014 Dec 22.

20.

ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.

Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN.

Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16.

21.

Relative safety of peginesatide and epoetin alfa.

Weinhandl ED, Gilbertson DT, Collins AJ, Foley RN.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1003-11. doi: 10.1002/pds.3655. Epub 2014 Jun 6.

PMID:
24905967
22.

End-stage renal disease from human immunodeficiency virus–associated nephropathy in the United States, 2001 through 2010.

Sexton DJ, Reule S, Solid C, Collins AJ, Foley RN.

JAMA Intern Med. 2014 May;174(5):809-11. No abstract available.

23.

Early mortality in patients starting dialysis appears to go unregistered.

Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ.

Kidney Int. 2014 Aug;86(2):392-8. doi: 10.1038/ki.2014.15. Epub 2014 Feb 12.

24.

Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation.

Solid CA, Collins AJ, Ebben JP, Chen SC, Faravardeh A, Foley RN, Ishani A.

BMC Nephrol. 2014 Feb 8;15:30. doi: 10.1186/1471-2369-15-30.

25.

Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease.

Williams CE, Curtis BM, Randell EW, Foley RN, Parfrey PS.

Can J Kidney Health Dis. 2014 Jul 15;1:16. doi: 10.1186/2054-3581-1-16. eCollection 2014.

26.

US Renal Data System 2013 Annual Data Report.

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001. Review. No abstract available.

PMID:
24360288
27.

Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009.

Foley RN, Solid CA, Lamb K.

Hemodial Int. 2014 Jan;18(1):24-31. doi: 10.1111/hdi.12090. Epub 2013 Oct 17.

PMID:
24131588
28.

High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization.

Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN, Kalra PA.

Am J Kidney Dis. 2014 Feb;63(2):186-97. doi: 10.1053/j.ajkd.2013.07.020. Epub 2013 Sep 26.

PMID:
24074824
29.

KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L.

Am J Kidney Dis. 2013 Nov;62(5):849-59. doi: 10.1053/j.ajkd.2013.06.008. Epub 2013 Jul 25.

PMID:
23891356
30.

Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort.

Hoefield RA, Kalra PA, Lane B, O'Donoghue DJ, Foley RN, Middleton RJ.

QJM. 2013 Oct;106(10):915-24. doi: 10.1093/qjmed/hct115. Epub 2013 Jun 29.

PMID:
23813282
31.

US Renal Data System 2012 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2013 Jan;61(1 Suppl 1):A7, e1-476. doi: 10.1053/j.ajkd.2012.11.031. No abstract available.

PMID:
23253259
32.

The USRDS: what you need to know about what it can and can't tell us about ESRD.

Foley RN, Collins AJ.

Clin J Am Soc Nephrol. 2013 May;8(5):845-51. doi: 10.2215/CJN.06840712. Epub 2012 Nov 2.

33.

A decade after the KDOQI CKD guidelines: impact on the United States and global public policy.

Collins AJ, Foley RN.

Am J Kidney Dis. 2012 Nov;60(5):697-700. doi: 10.1053/j.ajkd.2012.08.015. No abstract available.

PMID:
23067633
34.

Urolithiasis and the risk of ESRD.

El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1409-15. Epub 2012 Jun 28.

35.

Alternate-day dialysis may be needed for hemodialysis patients.

Liu J, Foley RN.

Kidney Int. 2012 Jun;81(11):1055-7. doi: 10.1038/ki.2012.31.

36.

Treatment of anemia in chronic kidney disease: known, unknown, and both.

Foley RN.

J Blood Med. 2011;2:103-12. doi: 10.2147/JBM.S13066. Epub 2011 Aug 1.

37.

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2012 Jan;59(1 Suppl 1):A7, e1-420. doi: 10.1053/j.ajkd.2011.11.015. No abstract available.

PMID:
22177944
38.

FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients.

Holden RM, Beseau D, Booth SL, Adams MA, Garland JS, Morton RA, Collier CP, Foley RN.

Hemodial Int. 2012 Jan;16(1):53-8. doi: 10.1111/j.1542-4758.2011.00630.x.

PMID:
22099949
39.

A novel model of cardiovascular risk based on kidney function.

Foley RN, Collins AJ.

Am J Nephrol. 2011;34(6):505-11. doi: 10.1159/000332997. Epub 2011 Nov 1. Review.

40.

Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease.

Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA.

Nephrol Dial Transplant. 2012 Apr;27(4):1403-9. doi: 10.1093/ndt/gfr496. Epub 2011 Oct 12.

PMID:
21993376
41.

Long interdialytic interval and mortality among patients receiving hemodialysis.

Foley RN, Gilbertson DT, Murray T, Collins AJ.

N Engl J Med. 2011 Sep 22;365(12):1099-107. doi: 10.1056/NEJMoa1103313.

42.

Why is mortality higher on certain dialysis shifts?

Foley RN.

Semin Dial. 2011 Jul-Aug;24(4):415-7. doi: 10.1111/j.1525-139X.2011.00931.x. Epub 2011 Jul 31. No abstract available.

PMID:
21801227
43.

Kidney function reference values in US adolescents: National Health And Nutrition Examination Survey 1999-2008.

Chavers BM, Rheault MN, Foley RN.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1956-62. doi: 10.2215/CJN.10311110. Epub 2011 Jul 22.

44.

Declining renal function in persons of different race without chronic kidney disease.

Foley RN, Collins AJ.

J Am Soc Nephrol. 2011 Jul;22(7):1183-4. doi: 10.1681/ASN.2011050521. Epub 2011 Jun 30. No abstract available.

45.

Chronic kidney disease: Levels of phosphorus and patient outcomes.

Foley RN.

Nat Rev Nephrol. 2011 Jun 28;7(8):428-30. doi: 10.1038/nrneph.2011.87. No abstract available.

PMID:
21712850
46.

Cardiovascular mortality in the general population versus dialysis: a glass half full or empty?

Sarnak MJ, Foley RN.

Am J Kidney Dis. 2011 Jul;58(1):4-6. doi: 10.1053/j.ajkd.2011.04.004. No abstract available.

PMID:
21684435
47.

A perfect cardiomyopathic storm.

Foley RN.

Semin Dial. 2011 May-Jun;24(3):278-9. doi: 10.1111/j.1525-139X.2011.00863.x. Epub 2011 May 12. No abstract available.

PMID:
21564299
48.

Cognitive impairment in peritoneal dialysis patients.

Kalirao P, Pederson S, Foley RN, Kolste A, Tupper D, Zaun D, Buot V, Murray AM.

Am J Kidney Dis. 2011 Apr;57(4):612-20. doi: 10.1053/j.ajkd.2010.11.026. Epub 2011 Feb 4. Erratum in: Am J Kidney Dis. 2011 Jun;57(6):966.

49.

Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007.

Li S, Chen YW, Peng Y, Foley RN, St Peter WL.

Am J Kidney Dis. 2011 Apr;57(4):602-11. doi: 10.1053/j.ajkd.2010.10.041. Epub 2010 Dec 24.

PMID:
21186072
50.

US Renal Data System 2010 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2011 Jan;57(1 Suppl 1):A8, e1-526. doi: 10.1053/j.ajkd.2010.10.007. No abstract available.

PMID:
21184928

Supplemental Content

Loading ...
Support Center